<!DOCTYPE html>
<html lang="en-us">
  <head>
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    
    <title>Posts | Fallingstar Daily R</title>
    <link rel="stylesheet" href="/css/style.css" />
    <link rel="stylesheet" href="/css/fonts.css" />
    <link href="//cdn.bootcss.com/highlight.js/9.12.0/styles/github.min.css" rel="stylesheet">

  </head>

  <body>
    <nav class="header">
      <div class="banner">
<a href="/" class="text">
&Ffr;&Afr;&Lfr;&Lfr;&Ifr;&Nfr;&Gfr;&Sfr;&Tfr;&Afr;&Rfr; &Dfr;&Afr;&Ifr;&Lfr;&Yfr; &Rfr;
</a>
</div>

      <div class="head-meta">
      
        <span>Posts</span>
        <span>2024-10-05</span>
      
      </div>
    </nav>


<div class="container">
<main class="list">

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39367710/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241005190914&amp;v=2.18.0.post9&#43;e462414">Mechanisms linking prenatal environment and linear growth: the case of Ramadan during pregnancy</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-05</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39367710-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241005190914-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Despite established links between prenatal nutritional deprivation and impaired offspring growth, the underlying dynamics and potential moderators remain largely unexplored. This study investigates the dynamics underlying Ramadan during pregnancy and its associations with children&rsquo;s linear growth, using data from the Indonesian Family Life Survey (1993 - 2015). We exploit Ramadan during pregnancy as a natural experiment, separating exposure from maternal background characteristics and season &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OAc51FbO1">🔻俄语的意思是：“你要去哪？” [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oac51fbo1/">
    
    
    
    
    
      
    
    🔻俄语的意思是：“你要去哪？” <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OAcAjk9kF">其实杭州的餐饮给我有一点很深的印象：稍微有点名气的，晚上打烊也太早了。 - 转发 @包容万物恒河水:&amp;ensp;🔻哎广州的食物比杭州确实好吃太多了。</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oacajk9kf/">
    
    
    
    
    
      
    
    其实杭州的餐饮给我有一点很深的印象：稍微有点名气的，晚上打烊也太早了。<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@包容万物恒河水<!-- raw HTML omitted -->: 🔻哎广州的食物比杭州确实好吃太多了。 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OAcgJjwPk">🔻准备了吗？🔻右：美军中央司令部司令。 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oacgjjwpk/">
    
    
    
    
    
      
    
    🔻准备了吗？<!-- raw HTML omitted -->🔻右：美军中央司令部司令。 <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OAcnrvsIg">🔻F24数据显示：美军 E-3 正在地中海东侧飞行。🔻上次刺杀纳斯鲁拉的时候，也是这样的飞行。#中东滑向全面战争# [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oacnrvsig/">
    
    
    
    
    
      
    
    🔻F24数据显示：美军 E-3 正在地中海东侧飞行。<!-- raw HTML omitted -->🔻上次刺杀纳斯鲁拉的时候，也是这样的飞行。<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#中东滑向全面战争#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OAcqmuNlr">🔻“伊朗大学是不是只提供两个学位？1.导弹生产，2.视频剪辑？”🔻via vk#中东滑向全面战争##热门视频# 包容万物恒河水的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oacqmunlr/">
    
    
    
    
    
      
    
    🔻“伊朗大学是不是只提供两个学位？1.导弹生产，2.视频剪辑？”<!-- raw HTML omitted -->🔻via vk<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#中东滑向全面战争#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#热门视频#<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;a href=&ldquo;<a href="https://video.weibo.com">https://video.weibo.com</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OAcx0eMZ1">🔻哎广州的食物比杭州确实好吃太多了。</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oacx0emz1/">
    
    
    
    
    
      
    
    🔻哎广州的食物比杭州确实好吃太多了。  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OAcyjg0cE">……如果我说我买了好几包点都德的袋装腊肠，会被笑吗？//@LEUNG-wai_bun:[怒]点都德和陶陶居吃了吗 - 转发 @包容万物恒河水:&amp;ensp;🔻哎广州的食物比杭州确实...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oacyjg0ce/">
    
    
    
    
    
      
    
    ……如果我说我买了好几包点都德的袋装腊肠，会被笑吗？//<!-- raw HTML omitted -->@LEUNG-wai_bun<!-- raw HTML omitted -->:<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->点都德和陶陶居吃了吗<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@包容万物恒河水<!-- raw HTML omitted -->: 🔻哎广州的食物比杭州确实好吃太多了。 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OAcyJxNDU">杭州总的来说也还行。但是谈不上特别好吃。//@阿田6677:广州好吃我知道，杭州真的真的难吃么？ - 转发 @包容万物恒河水:&amp;ensp;🔻哎广州的食物比杭州确实好吃太...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oacyjxndu/">
    
    
    
    
    
      
    
    杭州总的来说也还行。但是谈不上特别好吃。//<!-- raw HTML omitted -->@阿田6677<!-- raw HTML omitted -->:广州好吃我知道，杭州真的真的难吃么？<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@包容万物恒河水<!-- raw HTML omitted -->: 🔻哎广州的食物比杭州确实好吃太多了。 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OAeDjCymF">🔻伊朗当局称：由于军事演习的原因，发布飞行通告（NotAM），从耶路撒冷时间 10 月 5 日 20 时 至 10 月 9 日 4 时 30 分，每晚关闭西部边境沿线的空中通道。...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oaedjcymf/">
    
    
    
    
    
      
    
    🔻伊朗当局称：由于军事演习的原因，发布飞行通告（NotAM），从耶路撒冷时间 10 月 5 日 20 时 至 10 月 9 日 4 时 30 分，每晚关闭西部边境沿线的空中通道。<!-- raw HTML omitted -->🔻via IRNA 通讯社<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#中东滑向全面战争#<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/639b1bfbly1huc4n8riaqj21im1f9kjl.jpg%22">https://tvax3.sinaimg.cn/large/639b1bfbly1huc4n8riaqj21im1f9kjl.jpg&quot;</a> referrerpolicy=&ldquo;no-refer &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OAepBCtmi">🔻半岛电视台记者称，以军对贝鲁特南郊连续发动空袭。🔻记者巴达维报道称，以色列连续袭击该郊区后发生了强烈爆炸，并补充说其中一次袭击针对的是美国社区。...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oaepbctmi/">
    
    
    
    
    
      
    
    🔻半岛电视台记者称，以军对贝鲁特南郊连续发动空袭。<!-- raw HTML omitted -->🔻记者巴达维报道称，以色列连续袭击该郊区后发生了强烈爆炸，并补充说其中一次袭击针对的是美国社区。<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#中东滑向全面战争#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OA8UmwqVV">谁干的？谁干的？？？！！ - 转发 @麦当劳:&amp;ensp;？？？板烧下线了？？？？？ [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-oa8umwqvv/">
    
    
    
    
    
      
    
    谁干的？谁干的？？？！！<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@麦当劳<!-- raw HTML omitted -->: ？？？板烧下线了？？？？？ <!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OA8X4wLmd">舅舅挑选了这个美丽的午后整顿店里的布局本人没拍上什么用场大概是起到了一个装饰的作用</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-oa8x4wlmd/">
    
    
    
    
    
      
    
    舅舅挑选了这个美丽的午后整顿店里的布局<!-- raw HTML omitted -->本人没拍上什么用场大概是起到了一个装饰的作用  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OA9b56GWT">真是越长大越觉得我爹有病</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-oa9b56gwt/">
    
    
    
    
    
      
    
    真是越长大越觉得我爹有病  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OA9eLnIiC">过年的时候家里吵了好几架我爹想着法跟我说教还挑拨离间上了说我跟我姐姐妹妹现在要好都是假的要好以后结婚了还这样每天在一起才是真的好然后又说你们整天在一起...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-oa9elniic/">
    
    
    
    
    
      
    
    过年的时候家里吵了好几架<!-- raw HTML omitted -->我爹想着法跟我说教还挑拨离间上了<!-- raw HTML omitted -->说我跟我姐姐妹妹现在要好都是假的要好<!-- raw HTML omitted -->以后结婚了还这样每天在一起才是真的好<!-- raw HTML omitted -->然后又说你们整天在一起也不行你们老公会生气的<!-- raw HTML omitted -->（惹那个时候就知道他不喜欢妈妈天天跟她娘家人在一起他自己破防了）<!-- raw HTML omitted -->反正就是人无语的时候真的会笑  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OAa8esK7H">上个b班随机被大人吓死今晚算钱我那台机子少了一千六总数加起来又少五百多三个人不信邪算了一遍又一遍最终还是差钱吃饭的时候三个大人（四个人吃饭还有个我舅）...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-oaa8esk7h/">
    
    
    
    
    
      
    
    上个b班随机被大人吓死<!-- raw HTML omitted -->今晚算钱我那台机子少了一千六<!-- raw HTML omitted -->总数加起来又少五百多<!-- raw HTML omitted -->三个人不信邪算了一遍又一遍最终还是差钱<!-- raw HTML omitted -->吃饭的时候三个大人（四个人吃饭还有个我舅）<!-- raw HTML omitted -->一起复盘，不知道哪里出了差错，叔伯也问我有没有买什么东西有没有人拿着单子来找我我说没有<!-- raw HTML omitted -->然后我舅突然说<!-- raw HTML omitted -->是不是之前哪个学校的单子正好是一千六<!-- raw HTML omitted -->我隔壁的伯伯说还真有这个单子没撕起来<!-- raw HTML omitted -->但是不确定这钱进帐户了没<!-- raw HTML omitted --><!-- raw HTML omitted -->妈的吓死我了我都想好拿我工资去填这一千六了 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OAbrDkcYr">离婚，真的 - 转发 @麦当劳:&amp;ensp;如果有天板烧下架了，你会____。#深夜开麦# [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-oabrdkcyr/">
    
    
    
    
    
      
    
    离婚，真的<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@麦当劳<!-- raw HTML omitted -->: 如果有天板烧下架了，你会____。<!-- raw HTML omitted --><!-- raw HTML omitted -->#深夜开麦#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OAbrrDJom">洗澡洗一半没热水了，现在肚子冰冰的[举车]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-oabrrdjom/">
    
    
    
    
    
      
    
    洗澡洗一半没热水了，现在肚子冰冰的<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OAbwzBPcW">转发微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里 via.緒行记fb [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-oabwzbpcw/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --> via.緒行记fb &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/006z6nxLgy1hubmroaqncj30u00k0410.jpg%22">https://tvax2.sinaimg.cn/large/006z6nxLgy1hubmroaqncj30u00k0410.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OAeT62nJc">转发微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里#久保史绪里手机博# 2024.10.01 15:26(补)「哟」心情愉快今天感觉能时隔许久地睡个好觉，也感觉秋天的衣服不够用了...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-oaet62njc/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?cont">https://m.weibo.cn/search?cont</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OAeTdolKs">[亲亲][亲亲][亲亲] - 转发 @顶筆TEN使:&amp;ensp;久保史绪里#久保史绪里手机博# 2024.10.01 15:30(补)「欸嘿嘿」&lt;图&gt;说起来早前跟好喜欢好喜欢的朋友见面啦☺︎时隔...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-oaetdolks/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OA9tep0XX">久保史绪里 via.緒行记fb [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oa9tep0xx/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --> via.緒行记fb <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OAcFmwf82">久保史绪里#久保史绪里手机博# 2024.10.01 15:26(补)「哟」心情愉快今天感觉能时隔许久地睡个好觉，也感觉秋天的衣服不够用了、、、感觉不必心急、、但也感觉有...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oacfmwf82/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%25">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OAcHBFG3A">久保史绪里#久保史绪里手机博# 2024.10.01 15:30(补)「欸嘿嘿」&lt;图&gt;说起来早前跟好喜欢好喜欢的朋友见面啦☺︎时隔许久能有这样的时光聊了很多，让我心情很高兴...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oachbfg3a/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9A%23&amp;amp;isnewpa">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9A%23&amp;amp;isnewpa</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39363334/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241004202135&amp;v=2.18.0.post9&#43;e462414">Consensus statements for the establishment of medical intensive care in low-resource settings: international study using modified Delphi methodology</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39363334-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241004202135-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Delphi process identified a set of consensus-based statements on how to create a sustainable patient-centered medical intensive care in &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39363334/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241005190914&amp;v=2.18.0.post9&#43;e462414">Consensus statements for the establishment of medical intensive care in low-resource settings: international study using modified Delphi methodology</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39363334-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241005190914-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Delphi process identified a set of consensus-based statements on how to create a sustainable patient-centered medical intensive care in &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39363441/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241004202135&amp;v=2.18.0.post9&#43;e462414">Systematic review of environmental noise in neonatal intensive care units</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39363441-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241004202135-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: All NICUs exceeded recommended accumulative sound levels. People were the most consistent source of noise. Sound pressure levels need to be consistently measured with devices adhering to international SLM standards in future &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39363441/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241005190914&amp;v=2.18.0.post9&#43;e462414">Systematic review of environmental noise in neonatal intensive care units</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39363441-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241005190914-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: All NICUs exceeded recommended accumulative sound levels. People were the most consistent source of noise. Sound pressure levels need to be consistently measured with devices adhering to international SLM standards in future &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39363862/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241004202135&amp;v=2.18.0.post9&#43;e462414">Outcome of adult acute myeloid leukemia patients with extramedullary disease and treatment with venetoclax/hypomethylating agents</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39363862-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241004202135-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    We evaluated response to VEN/HMA in 46 patients with acute myeloid leukemia (AML) characterized by extramedullary disease (EMD). Median age was 65 (range, 19-81) years. Patients had a median of two EMD sites (range, 1-5) and 35 (76%) patients had concurrent bone marrow involvement. Twenty (43%) patients had highrisk genetic features according to the European Leukemia Net 2022 classification. Twenty-nine (63%) were relapsed or refractory after intensive chemotherapy (CTX) including 13 (28%) &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39363862/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241005190914&amp;v=2.18.0.post9&#43;e462414">Outcome of adult acute myeloid leukemia patients with extramedullary disease and treatment with venetoclax/hypomethylating agents</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39363862-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241005190914-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    We evaluated response to VEN/HMA in 46 patients with acute myeloid leukemia (AML) characterized by extramedullary disease (EMD). Median age was 65 (range, 19-81) years. Patients had a median of two EMD sites (range, 1-5) and 35 (76%) patients had concurrent bone marrow involvement. Twenty (43%) patients had highrisk genetic features according to the European Leukemia Net 2022 classification. Twenty-nine (63%) were relapsed or refractory after intensive chemotherapy (CTX) including 13 (28%) &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39363864/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20241004202124&amp;v=2.18.0.post9&#43;e462414">Pirtobrutinib monotherapy in Bruton tyrosine kinase inhibitor-intolerant patients with B-cell malignancies: results of the phase I/II BRUIN trial</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39363864-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20241004202124-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Bruton tyrosine kinase inhibitors (BTKi) have transformed the treatment of B-cell malignancies, but intolerance has often led to their discontinuation. The phase 1/2 BRUIN study evaluated pirtobrutinib, a highly selective non-covalent (reversible) BTKi, in patients with R/R B-cell malignancies (NCT03740529). Pirtobrutinib was investigated in 127 patients with intolerance to at least one prior BTKi therapy in the absence of progressive disease. The most common adverse event (AE) leading to &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39363864/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20241005190856&amp;v=2.18.0.post9&#43;e462414">Pirtobrutinib monotherapy in Bruton tyrosine kinase inhibitor-intolerant patients with B-cell malignancies: results of the phase I/II BRUIN trial</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39363864-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20241005190856-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Bruton tyrosine kinase inhibitors (BTKi) have transformed the treatment of B-cell malignancies, but intolerance has often led to their discontinuation. The phase 1/2 BRUIN study evaluated pirtobrutinib, a highly selective non-covalent (reversible) BTKi, in patients with R/R B-cell malignancies (NCT03740529). Pirtobrutinib was investigated in 127 patients with intolerance to at least one prior BTKi therapy in the absence of progressive disease. The most common adverse event (AE) leading to &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39363890/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241004202135&amp;v=2.18.0.post9&#43;e462414">Exploring public cancer gene expression signatures across bulk, single-cell and spatial transcriptomics data with signifinder Bioconductor package</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39363890-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241004202135-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Understanding cancer mechanisms, defining subtypes, predicting prognosis and assessing therapy efficacy are crucial aspects of cancer research. Gene-expression signatures derived from bulk gene expression data have played a significant role in these endeavors over the past decade. However, recent advancements in high-resolution transcriptomic technologies, such as single-cell RNA sequencing and spatial transcriptomics, have revealed the complex cellular heterogeneity within tumors, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39363890/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241005190914&amp;v=2.18.0.post9&#43;e462414">Exploring public cancer gene expression signatures across bulk, single-cell and spatial transcriptomics data with signifinder Bioconductor package</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39363890-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241005190914-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Understanding cancer mechanisms, defining subtypes, predicting prognosis and assessing therapy efficacy are crucial aspects of cancer research. Gene-expression signatures derived from bulk gene expression data have played a significant role in these endeavors over the past decade. However, recent advancements in high-resolution transcriptomic technologies, such as single-cell RNA sequencing and spatial transcriptomics, have revealed the complex cellular heterogeneity within tumors, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39365164/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241004202135&amp;v=2.18.0.post9&#43;e462414">A Remote Patient Monitoring System with Feedback Mechanisms using a Smartwatch: Concept, Implementation and Evaluation based on the activeDCM Randomized Controlled Trial</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39365164-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241004202135-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Our results mark a first step towards integrating RPM systems, based on a consumer wearable device for primary patient input, into standardized clinical workflows. They can serve as a blueprint for creating a user-friendly, reusable, interoperable and secure RPM system, that can be integrated into patients' daily &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39365164/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241005190914&amp;v=2.18.0.post9&#43;e462414">A Remote Patient Monitoring System with Feedback Mechanisms using a Smartwatch: Concept, Implementation and Evaluation based on the activeDCM Randomized Controlled Trial</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39365164-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241005190914-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Our results mark a first step towards integrating RPM systems, based on a consumer wearable device for primary patient input, into standardized clinical workflows. They can serve as a blueprint for creating a user-friendly, reusable, interoperable and secure RPM system, that can be integrated into patients' daily &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39365172/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241004202135&amp;v=2.18.0.post9&#43;e462414">Association of circulating fatty acids with cardiovascular disease risk: Analysis of individual-level data in three large prospective cohorts and updated meta-analysis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39365172-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241004202135-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Our study provides an overview of the most recent evidence on the associations between objectively measured FAs and CVD outcomes. Collectively, the data reveals notable differences in associations by SFA subtypes and calls for further studies, especially RCTs, to explore these &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39365172/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241005190914&amp;v=2.18.0.post9&#43;e462414">Association of circulating fatty acids with cardiovascular disease risk: Analysis of individual-level data in three large prospective cohorts and updated meta-analysis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39365172-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241005190914-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Our study provides an overview of the most recent evidence on the associations between objectively measured FAs and CVD outcomes. Collectively, the data reveals notable differences in associations by SFA subtypes and calls for further studies, especially RCTs, to explore these &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39365257/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20241004202134&amp;v=2.18.0.post9&#43;e462414">Safety and Efficacy of Standard of Care Ciltacabtagene Autoleucel for Relapsed/Refractory Multiple Myeloma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39365257-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20241004202134-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Ciltacabtagene autoleucel (cilta-cel) CAR-T therapy was approved in 2022 for patients with relapsed/refractory multiple myeloma (RRMM). We report outcomes with cilta-cel in the standard-of-care setting. Patients with RRMM who underwent leukapheresis for cilta-cel manufacturing between 3/1/2022-12/31/2022 at 16 US academic medical centers were included. RESULTS: 255 patients underwent leukapheresis and 236 (92.5%) received cilta-cel. Of leukapheresed patients, 56% would not have met &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39365257/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20241005190913&amp;v=2.18.0.post9&#43;e462414">Safety and Efficacy of Standard of Care Ciltacabtagene Autoleucel for Relapsed/Refractory Multiple Myeloma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39365257-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20241005190913-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Ciltacabtagene autoleucel (cilta-cel) CAR-T therapy was approved in 2022 for patients with relapsed/refractory multiple myeloma (RRMM). We report outcomes with cilta-cel in the standard-of-care setting. Patients with RRMM who underwent leukapheresis for cilta-cel manufacturing between 3/1/2022-12/31/2022 at 16 US academic medical centers were included. RESULTS: 255 patients underwent leukapheresis and 236 (92.5%) received cilta-cel. Of leukapheresed patients, 56% would not have met &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39365257/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20241004202124&amp;v=2.18.0.post9&#43;e462414">Safety and Efficacy of Standard of Care Ciltacabtagene Autoleucel for Relapsed/Refractory Multiple Myeloma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39365257-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20241004202124-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Ciltacabtagene autoleucel (cilta-cel) CAR-T therapy was approved in 2022 for patients with relapsed/refractory multiple myeloma (RRMM). We report outcomes with cilta-cel in the standard-of-care setting. Patients with RRMM who underwent leukapheresis for cilta-cel manufacturing between 3/1/2022-12/31/2022 at 16 US academic medical centers were included. RESULTS: 255 patients underwent leukapheresis and 236 (92.5%) received cilta-cel. Of leukapheresed patients, 56% would not have met &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39365257/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20241005190856&amp;v=2.18.0.post9&#43;e462414">Safety and Efficacy of Standard of Care Ciltacabtagene Autoleucel for Relapsed/Refractory Multiple Myeloma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39365257-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20241005190856-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Ciltacabtagene autoleucel (cilta-cel) CAR-T therapy was approved in 2022 for patients with relapsed/refractory multiple myeloma (RRMM). We report outcomes with cilta-cel in the standard-of-care setting. Patients with RRMM who underwent leukapheresis for cilta-cel manufacturing between 3/1/2022-12/31/2022 at 16 US academic medical centers were included. RESULTS: 255 patients underwent leukapheresis and 236 (92.5%) received cilta-cel. Of leukapheresed patients, 56% would not have met &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39365479/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241004202135&amp;v=2.18.0.post9&#43;e462414">Single mandibular implant study - impact on dietary habits after 5 years of observation in patients with immediate and delayed loading protocols</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39365479-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241004202135-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: A change in the patients' dietary habits due to the insertion of a single midline implant in the mandible to support the existing complete denture cannot be observed, independently to the loading &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39365479/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241005190914&amp;v=2.18.0.post9&#43;e462414">Single mandibular implant study - impact on dietary habits after 5 years of observation in patients with immediate and delayed loading protocols</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39365479-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241005190914-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: A change in the patients' dietary habits due to the insertion of a single midline implant in the mandible to support the existing complete denture cannot be observed, independently to the loading &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39366356/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241005190914&amp;v=2.18.0.post9&#43;e462414">Exploring the expanding universe of host-virus interactions mediated by viral RNA</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39366356-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241005190914-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    RNA is a central molecule in RNA virus biology; however, the interactions that it establishes with the host cell are only starting to be elucidated. In recent years, a methodology revolution has dramatically expanded the scope of host-virus interactions involving the viral RNA (vRNA). A second wave of method development has enabled the precise study of these protein-vRNA interactions in a life cycle stage-dependent manner, as well as providing insights into the interactome of specific &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39366358/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241005190914&amp;v=2.18.0.post9&#43;e462414">Let&#39;s get functional: Drug sensitivity profiling to enable precision sarcoma medicine</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39366358-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241005190914-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Drug sensitivity profiling in patient-derived tumor models offers new hope for improving outcomes in cancers lacking effective therapies. Al Shihabi et al.¹ demonstrate that short-term cultures from bone and soft tissue sarcomas enable clinically meaningful screening of multiple drugs and combinations, marking a significant advance in personalized care for these high-risk &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39366373/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241005190914&amp;v=2.18.0.post9&#43;e462414">Spark in the darkness: Discovering action potentials in brain tumors</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39366373-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241005190914-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Gliomas exhibit significant molecular diversity and poor prognosis. In this issue of Cancer Cell, Curry et al. apply Patch-seq on human glioma samples uncovering hybrid cells with glial and neuronal features, capable of firing action potentials in isocitrate dehydrogenase mutant gliomas. These findings highlight the importance of neural features in tumor biology and &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39366504/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241005190914&amp;v=2.18.0.post9&#43;e462414">Small-molecule mediated MuRF1 Inhibition protects from Doxorubicin-induced Cardiac Atrophy and Contractile Dysfunction</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39366504-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241005190914-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Cancer chemotherapy induces cell stress in rapidly dividing cancer cells to trigger their growth arrest and apoptosis. However, adverse effects related to cardiotoxicity underpinned by a limited regenerative potential of the heart limits clinical application: In particular, chemotherapy with doxorubicin (DOXO) causes acute heart injury that can transition to persisting cardiomyopathy (DOXO-CM). Here, we tested if MuRF1 inhibition (&ldquo;MuRFi&rdquo;) was able to attenuate DOXO-CM. To mimic &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39366628/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241005190914&amp;v=2.18.0.post9&#43;e462414">Evaluation of antioxidant and anti-inflammatory properties of Lacticaseibacillus rhamnosus Ram12-derived exopolysaccharide in a D-galactose-induced liver injury mouse model</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39366628-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241005190914-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    We investigated the antioxidant and anti-inflammatory properties of Lacticaseibacillus rhamnosus Ram12-derived EPSRam12 in a D-galactose-induced liver injury mouse model. Initially, EPSRam12 was characterized for its composition, molecular weight, and structural features. It was then administered orally to D-galactose-induced mice (which had received an intraperitoneal injection of D-galactose, 100 mg/kg body weight) at doses of 25 mg/kg (low dose) and 50 mg/kg (high dose) for 45 days. &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39366729/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241005190914&amp;v=2.18.0.post9&#43;e462414">Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39366729-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241005190914-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    BACKGROUND: Smoking is the leading behavioural risk factor for mortality globally, accounting for more than 175 million deaths and nearly 4·30 billion years of life lost (YLLs) from 1990 to 2021. The pace of decline in smoking prevalence has slowed in recent years for many countries, and although strategies have recently been proposed to achieve tobacco-free generations, none have been implemented to date. Assessing what could happen if current trends in smoking prevalence persist, and &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39366729/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20241005190856&amp;v=2.18.0.post9&#43;e462414">Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39366729-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20241005190856-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    BACKGROUND: Smoking is the leading behavioural risk factor for mortality globally, accounting for more than 175 million deaths and nearly 4·30 billion years of life lost (YLLs) from 1990 to 2021. The pace of decline in smoking prevalence has slowed in recent years for many countries, and although strategies have recently been proposed to achieve tobacco-free generations, none have been implemented to date. Assessing what could happen if current trends in smoking prevalence persist, and &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39366734/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20241005190856&amp;v=2.18.0.post9&#43;e462414">Systematic literature review of published cases of reactive plasmacytosis in peripheral blood and bone marrow</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39366734-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20241005190856-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: In patients with an increase in the number and/or proportion of plasma cells in peripheral blood and/or bone marrow, clinical context and a broad differential diagnosis are necessary to direct further evaluation and arrive at a correct diagnosis. Our literature review suggests that evaluation for infectious causes and AITL may be of the greatest yield in many &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39366918/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241005190914&amp;v=2.18.0.post9&#43;e462414">Unveiling the Complexity of cis-Regulation Mechanisms in Kinases: A Comprehensive Analysis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39366918-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241005190914-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Protein cis-regulatory elements (CREs) are regions that modulate the activity of a protein through intramolecular interactions. Kinases, pivotal enzymes in numerous biological processes, often undergo regulatory control via inhibitory interactions in cis. This study delves into the mechanisms of cis regulation in kinases mediated by CREs, employing a combined structural and sequence analysis. To accomplish this, we curated an extensive dataset of kinases featuring annotated CREs, organized &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39366943/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241005190914&amp;v=2.18.0.post9&#43;e462414">Author Correction: Compartments in medulloblastoma with extensive nodularity are connected through differentiation along the granular precursor lineage</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39366943-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241005190914-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39367019/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241005190914&amp;v=2.18.0.post9&#43;e462414">Patterns of intersectional tumor volumes in T2-weighted MRI and [&lt;sup&gt;18&lt;/sup&gt;F]FET PET in adult glioma: a prospective, observational study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39367019-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241005190914-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Brain tumor volumes as assessed by magnetic resonance imaging (MRI) do not always spatially overlap with biological tumor volumes (BTV) measured by [^(18)F]Fluoroethyltyrosine positron emission tomography ([^(18)F]FET PET). We prospectively investigated volumetric patterns based on the extent of tumor volume overlap between the two modalities. Eighty-six patients with newly diagnosed glioma who had undergone MRI and [^(18)F]FET PET between 2007 and 2009 were included in this prospective &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39367058/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241005190914&amp;v=2.18.0.post9&#43;e462414">Author Correction: High-resolution mapping of urban Aedes aegypti immature abundance through breeding site detection based on satellite and street view imagery</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39367058-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241005190914-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39367487/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241005190914&amp;v=2.18.0.post9&#43;e462414">Revisiting the scope and expectations of Implementation Science and Implementation Science Communications</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39367487-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241005190914-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    This editorial updates the scope and submission expectations of Implementation Science and Implementation Science Communications. We refine our protocol publishing policies and set out new expectations for reporting studies describing determinants and their relationship with implementation outcomes. Our central focus remains on the implementation of evidence-based interventions into healthcare practice and policy. We are most interested in rigorous empirical studies of the implementation &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/OzXuQr2ML">今天WaPo Podcast—Post Reports请了该机构负责选举民调（poll）副主任Emily Guskin科普了2024年大选民调。有两点很有意思。第一就是跟我猜想得一样，2024年大选...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-ozxuqr2ml/">
    
    
    
    
    
      
    
    今天WaPo Podcast—Post Reports请了该机构负责选举民调（poll）副主任Emily Guskin科普了2024年大选民调。有两点很有意思。第一就是跟我猜想得一样，2024年大选poll统计方法是进行了调整了的。Pollster每年的大会AAPC会讨论更新统计学抽样方法以去除偏倚，2024大选最重要的是调整受教育程度高和“不响应”poll两个人群的比重，以让poll结果更接近普通人群，但我觉得这样调整后的结果出现了很多反常识的现象，比如NYT/Siena poll会出现年轻或者女性选民大量支持R的情况。第二就是Guskin鼓励普通人去读poll的方法学。她认为越是公布详细方法学的poll越可靠，这点我很认可。好的poll非常科学客观，而差的poll具有强烈的诱导性。<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E7%25B">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E7%B</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/OzYRpFP9e">看临床试验的TEAE，几百页，细致到每个症状和体征，要把这些症状和体征按照临床分科进行分门别类，这时就是考察临床知识的时刻了，比如，Cellulitis或Osteomyeli...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-ozyrpfp9e/">
    
    
    
    
    
      
    
    看临床试验的TEAE，几百页，细致到每个症状和体征，要把这些症状和体征按照临床分科进行分门别类，这时就是考察临床知识的时刻了，比如，Cellulitis或Osteomyelitis是哪个科室的临床表现？Rhabdomyolysis是哪个专科的临床表现？Sciatica是哪个专科临床表现？Foreign body aspiration应该去哪个科室？  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OA2AdA70h">🔻Planet Labs 卫星图像显示内瓦提姆空军基地的 F-35 掩体和另一座建筑遭到袭击。🔻F-35 掩体天灵盖被开了洞。#伊朗以色列军事力量对比# [图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oa2ada70h/">
    
    
    
    
    
      
    
    🔻Planet Labs 卫星图像显示内瓦提姆空军基地的 F-35 掩体和另一座建筑遭到袭击。<!-- raw HTML omitted -->🔻F-35 掩体天灵盖被开了洞。<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#伊朗以色列军事力量对比#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->&lt;img &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OA2BLcT00">🔻以军官网要求以色列人不要上传任何来自抵抗之弧的袭击效果视频照片。🔻快进到学SBU抓人。#伊朗以色列军事力量对比# [图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oa2blct00/">
    
    
    
    
    
      
    
    🔻以军官网要求以色列人不要上传任何来自抵抗之弧的袭击效果视频照片。<!-- raw HTML omitted -->🔻快进到学SBU抓人。<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#伊朗以色列军事力量对比#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->&lt;img style=&quot;&quot; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OA2EG088e">🔻之前，以色列威胁说：“如果任何伊朗飞机降落在贝鲁特机场，我们将摧毁该飞机和机场。”🔻今天，伊朗外长亲自带领伊朗航班着陆贝鲁特。🔻还是很勇的。#...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oa2eg088e/">
    
    
    
    
    
      
    
    🔻之前，以色列威胁说：“如果任何伊朗飞机降落在贝鲁特机场，我们将摧毁该飞机和机场。”<!-- raw HTML omitted -->🔻今天，伊朗外长亲自带领伊朗航班着陆贝鲁特。<!-- raw HTML omitted -->🔻还是很勇的。<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#伊朗以色列军事力量对比#<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E7%83%AD%E9%97%A8%E8%A7%86%E9%A2%259">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E7%83%AD%E9%97%A8%E8%A7%86%E9%A2%9</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OA2OouqEX">🔻一个美国网友说：“我简直不敢相信今天看到的一切。我已经在外奔波了 12 个小时，为山区的人们运送物资。我去过杨西县、米切尔县、贝克斯维尔、斯普鲁斯派恩...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oa2oouqex/">
    
    
    
    
    
      
    
    🔻一个美国网友说：“我简直不敢相信今天看到的一切。我已经在外奔波了 12 个小时，为山区的人们运送物资。我去过杨西县、米切尔县、贝克斯维尔、斯普鲁斯派恩、伯恩斯维尔等地。我让一位老人继续使用发电机供氧，并陪他等到家人出现。我向人们发放了数千美元。他们没有路，没有电力，没有食物。人们奄奄一息。大男人们哭着拥抱我，因为我给了他们100美元。我明天还要再去发一次。今天的所见所闻让我感到恶心，我也断断续续哭了一整天，我通常不会这样。美国政府在小城镇的投放点没收物资，这就是为什么我要把所有东西直接带给人们。我和一个爱国者车队会合，我们把物资运到人们无法到达的地方，以及道路封闭的地方。我开着卡车到处跑，他们也开着卡车到处跑。”<!-- raw HTML omitted -->🔻——“ can&rsquo;t believe what I saw today. I&rsquo;ve been out for 12 hours bringing supplies to people up in the mountains. I was in Yancey County, Mitchell County, Bakersville, Spruce Pine, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OA2XNvRRl">🔻[微笑]🔻只有在我们这你才能看到这个。 [图片][图片][图片][图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oa2xnvrrl/">
    
    
    
    
    
      
    
    🔻<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->🔻只有在我们这你才能看到这个。 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sin">https://tvax1.sin</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OA2yYl3TB">这人干啥的？//@zfdgifjsjxf:秦霄贤被爆瓜，然后他家伪造了一篇人民网的新闻稿抹黑对方 - 转发 @包容万物恒河水:&amp;ensp;🔻这什么瓜？#假冒媒体岂是儿戏#</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oa2yyl3tb/">
    
    
    
    
    
      
    
    这人干啥的？//<!-- raw HTML omitted -->@zfdgifjsjxf<!-- raw HTML omitted -->:秦霄贤被爆瓜，然后他家伪造了一篇人民网的新闻稿抹黑对方<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@包容万物恒河水<!-- raw HTML omitted -->: 🔻这什么瓜？<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#假冒媒体岂是儿戏#<!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OA3748bZS">🔻关于这贴，有很多我们的网友认为“一个家庭怎么可能用这么多电”。🔻这里有@华义凛 的科普贴 网页链接 网页链接 网页链接🔻简单的说，就是从输电线路、...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oa3748bzs/">
    
    
    
    
    
      
    
    🔻关于这贴，有很多我们的网友认为“一个家庭怎么可能用这么多电”。<!-- raw HTML omitted -->🔻这里有<!-- raw HTML omitted -->@华义凛<!-- raw HTML omitted --> 的科普贴 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->网页链接<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn/">https://h5.sinaimg.cn/</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OA37tDl6Y">🔻但是左边支持巴勒斯坦，右边前以军、支持以色列。 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oa37tdl6y/">
    
    
    
    
    
      
    
    🔻但是左边支持巴勒斯坦，右边前以军、支持以色列。 <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OA3cu7LzG">6//@一行法师:但是左边歧视亚裔/乳化[doge]完美对冲了 - 转发 @包容万物恒河水:&amp;ensp;🔻但是左边支持巴勒斯坦，右边前以军、支持以色列。 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oa3cu7lzg/">
    
    
    
    
    
      
    
    6//<!-- raw HTML omitted -->@一行法师<!-- raw HTML omitted -->:但是左边歧视亚裔/乳化<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->完美对冲了<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@包容万物恒河水<!-- raw HTML omitted -->: 🔻但是左边支持巴勒斯坦，右边前以军、支持以色列。 <!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OA3wRBShV">🔻这个月的WOW商栈幻化真劲啊。 [图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oa3wrbshv/">
    
    
    
    
    
      
    
    🔻这个月的WOW商栈幻化真劲啊。 <!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OA0F1aWVz">等回去后一定买个生写架子（ [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-oa0f1awvz/">
    
    
    
    
    
      
    
    等回去后一定买个生写架子（ <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OA0g3mw1t">好想吃炸鸡</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-oa0g3mw1t/">
    
    
    
    
    
      
    
    好想吃炸鸡  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OA0GBxBGa">转发微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里 via.緒行记fb&amp;ins [图片][图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-oa0gbxbga/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --> via.緒行记fb&amp;ins &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/006z6nxLgy1huajag3kunj30u00j7q4l.jpg%22">https://tvax2.sinaimg.cn/large/006z6nxLgy1huajag3kunj30u00j7q4l.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OA0GK1mj6">背影吼吼看🥹 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里 via.乃木坂46 ins [图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-oa0gk1mj6/">
    
    
    
    
    
      
    
    背影吼吼看🥹<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --> via.乃木坂46 ins &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/006z6nxLgy1huajcbj8tmj3140140jwm.jpg%22">https://tvax2.sinaimg.cn/large/006z6nxLgy1huajcbj8tmj3140140jwm.jpg&quot;</a>  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OA0GY5H40">我勒个邦邦，好小众的活 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里#shiorigram# 10/14 星期一下午2点开始在E频道直播『第91届NHK全国学校音乐合唱比赛』我将担任初中...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-oa0gy5h40/">
    
    
    
    
    
      
    
    我勒个邦邦，好小众的活<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid">https://m.weibo.cn/search?containerid</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OA0H146Dg">急急急 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里#shiorigram# 被未来的我暴击！？公布了人物关系图距离播出还有3天..！好期待好期待拍摄现场到处飘荡着“暴击暴击～...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-oa0h146dg/">
    
    
    
    
    
      
    
    急急急<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23shiori">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23shiori</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OA0Kbc1ei">好好好 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-oa0kbc1ei/">
    
    
    
    
    
      
    
    好好好 <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OA55m1cFg">好险！差点就中文夹英文了[剑网3]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-oa55m1cfg/">
    
    
    
    
    
      
    
    好险！差点就中文夹英文了[剑网3]  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OzYEgmSGh">转发微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里#久保史绪里手机博# 2024.10.04 10:54「啊ー」早上好哦最近回过神来就过了好些日子必须好好生活想看的电影太多了怎...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ozyegmsgh/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%253">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OzYlgjI8e">好想吃蛙</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ozylgji8e/">
    
    
    
    
    
      
    
    好想吃蛙  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/OA05UDvFC">分享图片 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-oa05udvfc/">
    
    
    
    
    
      
    
    分享图片 <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/OA0E8c8Ev">轉發微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里 via.緒行记fb&amp;ins [图片][图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-oa0e8c8ev/">
    
    
    
    
    
      
    
    轉發微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --> via.緒行记fb&amp;ins &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/006z6nxLgy1huajag3kunj30u00j7q4l.jpg%22">https://tvax2.sinaimg.cn/large/006z6nxLgy1huajag3kunj30u00j7q4l.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/OA0Hm2V7A">爆擊？！ - 转发 @顶筆TEN使:&amp;ensp;久保史绪里#shiorigram# 被未来的我暴击！？公布了人物关系图距离播出还有3天..！好期待好期待拍摄现场到处飘荡着“暴击暴击...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-oa0hm2v7a/">
    
    
    
    
    
      
    
    爆擊？！<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23shior">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23shior</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/OA0KnznEN">轉發微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里#shiorigram# 10/14 星期一下午2点开始在E频道直播『第91届NHK全国学校音乐合唱比赛』我将担任初中组的嘉宾主持。...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-oa0knznen/">
    
    
    
    
    
      
    
    轉發微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522typ">https://m.weibo.cn/search?containerid=231522typ</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/OA1NN6DGk">連背影都好看[哇] - 转发 @顶筆TEN使:&amp;ensp;久保史绪里 via.乃木坂46 ins [图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-oa1nn6dgk/">
    
    
    
    
    
      
    
    連背影都好看<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://n.sinaimg.cn/photo/5213b46e/20180926/timeline_card_small_super_defa">https://n.sinaimg.cn/photo/5213b46e/20180926/timeline_card_small_super_defa</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OA0CbDpn0">久保史绪里#shiorigram# 10/14 星期一下午2点开始在E频道直播『第91届NHK全国学校音乐合唱比赛』我将担任初中组的嘉宾主持。能担任一直是梦寐以求的n con的主持...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oa0cbdpn0/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OA0FdzqU1">久保史绪里#shiorigram# 被未来的我暴击！？公布了人物关系图距离播出还有3天..！好期待好期待拍摄现场到处飘荡着“暴击暴击～”的声音。#暴击# [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oa0fdzqu1/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#shiorigram#&lt;/span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OA0wQi7Fa">久保史绪里 via.緒行记fb&amp;ins [图片][图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oa0wqi7fa/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --> via.緒行记fb&amp;ins <!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/006z6nxLgy1huajagi2ttj">https://tvax3.sinaimg.cn/large/006z6nxLgy1huajagi2ttj</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OA0xCAKQX">久保史绪里 via.乃木坂46 ins [图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oa0xcakqx/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --> via.乃木坂46 ins <!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/006z6nxLgy1huajcbz3ajj31">https://tvax1.sinaimg.cn/large/006z6nxLgy1huajcbz3ajj31</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OzXFe28eh">久保史绪里#久保史绪里手机博# 2024.10.04 10:54「啊ー」早上好哦最近回过神来就过了好些日子必须好好生活想看的电影太多了怎么办，看了一直在看电视剧的大结局...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ozxfe28eh/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9A%23">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9A%23</a>&amp; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.gimp.org/news/2024/10/05/development-update/">Development Update: Closing In on the 3.0 Release Candidate</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-04</span>
  </div>
  <div class="summary">
    <a href="/post/www-gimp-org-news-2024-10-05-development-update/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

</main>
</div>

<script async src="//yihui.name/js/center-img.js"></script>

<footer>

<div class="footer">
  <ul class="menu">
    
    <li><a href="/"><span data-hover="Home">Home</span></a></li>
    
    <li><a href="/about/"><span data-hover="About">About</span></a></li>
    
    <li><a href="/archives/"><span data-hover="Archive">Archive</span></a></li>
    
    <li><a href="/contributor/"><span data-hover="Contributor">Contributor</span></a></li>
    
    <li><a href="/index.xml"><span data-hover="Subscribe">Subscribe</span></a></li>
    
  </ul>
  
  <div class="copyright">© <a href="https://rainoffallingstar.github.io">Fallingstar</a> 2023 | <a href="https://github.com/rainoffallingstar">Github</a></div>
  
</div>
</footer>







</body>
</html>

